Reviva Pharmaceuticals Company Insiders
| RVPHW Stock | USD 0.23 0.04 21.05% |
Reviva Pharmaceuticals employs about 15 people. The company is managed by 3 executives with a total tenure of roughly 35 years, averaging almost 11.0 years of service per executive, having 5.0 employees per reported executive. Recap of Reviva Pharmaceuticals' management performance can provide insight into the venture performance.
Reviva |
Reviva Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (2.3395) % which means that it has lost $2.3395 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (17.9506) %, meaning that it generated substantial loss on money invested by shareholders. Reviva Pharmaceuticals' management efficiency ratios could be used to measure how well Reviva Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to about (1.6 M) in 2024. Return On Capital Employed is likely to climb to about (5.8 M) in 2024. At this time, Reviva Pharmaceuticals' Other Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 504.5 K in 2024, whereas Total Assets are likely to drop slightly above 18.2 M in 2024.Common Stock Shares Outstanding is likely to drop to about 15 M in 2024
Reviva Pharmaceuticals Workforce Comparison
Reviva Pharmaceuticals Holdings is rated third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 124. Reviva Pharmaceuticals retains roughly 15.0 in number of employees claiming about 12% of equities under Health Care industry.
Reviva Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Reviva Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Reviva Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Reviva Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Patel Purav 3 days ago Discretionary transaction by Patel Purav of tradable shares of Reviva Pharmaceuticals subject to Rule 16b-3 | ||
Laxminarayan Bhat over six months ago Acquisition by Laxminarayan Bhat of 443000 shares of Reviva Pharmaceuticals at 6.74 subject to Rule 16b-3 | ||
Saxena Parag over six months ago Acquisition by Saxena Parag of 4000 shares of Reviva Pharmaceuticals at 4.73 subject to Rule 16b-3 |
Reviva Pharmaceuticals Notable Stakeholders
A Reviva Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Reviva Pharmaceuticals often face trade-offs trying to please all of them. Reviva Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Reviva Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marc Cantillon | Chief Officer | Profile | |
| Narayan Prabhu | Chief Officer | Profile | |
| Laxminarayan Bhat | CEO, Founder | Profile |
About Reviva Pharmaceuticals Management Performance
The success or failure of an entity such as Reviva Pharmaceuticals often depends on how effective the management is. Reviva Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Reviva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Reviva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | -1.7 M | -1.6 M | |
| Return On Capital Employed | -6.1 M | -5.8 M | |
| Return On Assets | -1.7 M | -1.6 M | |
| Return On Equity | -6.9 M | -6.5 M |
Please note, the imprecision that can be found in Reviva Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Reviva Pharmaceuticals Holdings. Check Reviva Pharmaceuticals' Beneish M Score to see the likelihood of Reviva Pharmaceuticals' management manipulating its earnings.
Reviva Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Reviva Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Reviva Pharmaceuticals within its industry.Reviva Pharmaceuticals Manpower Efficiency
Return on Reviva Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2.6M | |
| Net Loss Per Executive | 13.1M | |
| Working Capital Per Employee | 435K | |
| Working Capital Per Executive | 2.2M |
Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.